Nancy Marie Allen LaPointe

Nancy Marie Allen LaPointe
Adjunct Associate Professor in the Department of Medicine

Patient Safety
Medication Adherence
Evidence-based Medications
Health Literacy
Risk Communication
Atrial Fibrillation
Sudden Cardiac Death

Current Appointments & Affiliations

Adjunct Associate Professor in the Department of Medicine, Medicine, Cardiology, Medicine 2015
Member in the Duke Clinical Research Institute, Duke Clinical Research Institute, Institutes and Centers 2004

Contact Information

Unpublished, Raleigh, NC 27607
Unpublished, Durham, NC 27710
nancy.allenlapointe@duke.edu

Background
Education, Training, & Certifications
- M.H.S., Duke University 2013
- Pharm.D., Purdue University 1988
Duke Appointment History
- Associate Professor in Medicine, Medicine, Clinical Pharmacology, Medicine 2008 - 2015
- Associate Professor in Medicine, Medicine, Clinical Pharmacology, Medicine 2006 - 2008
- Associate Clinical Professor in Medicine, Medicine, Clinical Pharmacology, Medicine 2004 - 2006
Research
Selected Grants
- Educational Videos to Reduce Racial Disparities in ICD therapy Via Innovative Designs (VIVID) awarded by Patient-Centered Outcomes Research Institute 2016 - 2019
- Pharmacogenetic Testing: Challenges of Clinical Integration awarded by National Institutes of Health 2011 - 2019
- Value of Information Analysis: PCORnet Aspirin Maintenance Doseage Trial awarded by Patient-Centered Outcomes Research Institute 2015 - 2016
- Pharmacogenetic Testing: Challenges of Clinical Integration awarded by National Institutes of Health 2007 - 2015
- Duke Cardiovascular CERTs awarded by Agency for Healthcare Research and Quality 2007 - 2012
- Improving Quality through Decision Support for Evidence-Based Pharmacotherapy awarded by Agency for Healthcare Research and Quality 2007 - 2011
- EPC_TO#3_WA#7_Anemia Management in Renal Disease Populations - Part 2 awarded by Agency for Healthcare Research and Quality 2010
- EPC _TO #1_WA #3_Anemia Management in Renal Disease Populations - (Part 1) awarded by Agency for Healthcare Research and Quality 2010
- Safer Antithrombotic Therapy for Elderly ACS Patients awarded by National Institutes of Health 2005 - 2008
- DCRI Research Center for CERTs awarded by Agency for Healthcare Research and Quality 1999 - 2008
- DCRI CERT for Cardiovascular Therapies awarded by National Institutes of Health 1999 - 2002
Publications & Artistic Works
Selected Publications
- Academic Articles
  - Borre, ED, Goode, A, Raitz, G, Shah, B, Lowenstern, A, Chatterjee, R, Sharan, L, Allen LaPointe, NM, Yapa, R, Davis, JK, Lallinger, K, Schmidt, R, Kosinski, A, Al-Khatib, SM, and Sanders, GD. "Predicting Thromboembolic and Bleeding Event Risk in Patients with Non-Valvular Atrial Fibrillation: A Systematic Review." Thrombosis and Haemostasis (October 30, 2018). Full Text
  - Hess, CN, Rogers, RK, Wang, TY, Fu, R, Gundrum, J, Allen LaPointe, NM, and Hiatt, WR. "Major Adverse Limb Events and 1-Year Outcomes After Peripheral Artery Revascularization." Journal of the American College of Cardiology 72, no. 9 (August 2018): 999-1011. Full Text
  - Goode, AP, Coeytaux, RR, Maslow, GR, Davis, N, Hill, S, Namdari, B, LaPointe, NMA, Befus, D, Lallinger, KR, Bowen, SE, Kosinski, A, McBroom, AJ, Sanders, GD, and Kemper, AR. "Nonpharmacologic Treatments for Attention-Deficit/Hyperactivity Disorder: A Systematic Review." Pediatrics 141, no. 6 (June 2018). (Review) Full Text
  - Pokorney, SD, Yen, DC, Campbell, KB, Allen LaPointe, NM, Sheng, S, Thomas, L, Bahnson, TD, Daubert, JP, Picini, JP, Jackson, KP, Thomas, KL, and Al-Khatib, SM. "Dofetilide dose reductions and discontinuations in women compared with men." Heart Rhythm 15, no. 4 (April 2018): 478-484. Full Text
  - Anderson, ML, Peragallo Urrutia, R, O'Brien, EC, Allen LaPointe, NM, Christian, AJ, Kaltenbach, LA, Webb, LE, Alexander, AM, Saha Chaudhuri, P, Crawford, J, Wayte, P, and Peterson, ED. "Outcomes of a multi-community hypertension implementation study: the American Heart Association's Check. Change. Control. program." Journal of Clinical Hypertension (Greenwich, Conn.) 19, no. 5 (May 2017): 479-487. Full Text
  - Pokorney, SD, Mi, X, Hammill, BG, Allen LaPointe, NM, Curtis, LH, and Al-Khatib, SM. "Use of Antiarrhythmic Medications in Medicare Part D Patients With an Implantable Cardioverter-Defibrillator and Ventricular Tachycardia." The American Journal of Cardiology 119, no. 9 (May 2017): 1401-1406. Full Text
  - Haga, SB, Mills, R, Moaddeb, J, Allen LaPointe, N, Cho, A, and Ginsburg, GS. "Primary care providers' use of pharmacist support for delivery of pharmacogenetic testing." Pharmacogenomics 18, no. 4 (March 2017): 359-367. Full Text
  - Haga, SB, Mills, R, Moaddeb, J, Allen Lapointe, N, Cho, A, and Ginsburg, GS. "Patient experiences with pharmacogenetic testing in a primary care setting." Pharmacogenomics 17, no. 15 (October 2016): 1629-1636. Full Text
  - Duan-Porter, W, Goldstein, KM, McDuffie, JR, Hughes, JM, Clowse, MEB, Klap, RS, Masilamani, V, Allen LaPointe, NM, Nagi, A, Gierisch, JM, and Williams, JW. "Reporting of Sex Effects by Systematic Reviews on Interventions for Depression, Diabetes, and Chronic Pain." Annals of internal medicine 165, no. 3 (August 2016): 184-193. Full Text
  - Haga, SB, Moaddeb, J, Mills, R, Patel, M, Kraus, W, and Allen LaPointe, NM. "Incorporation of pharmacogenetic testing into medication therapy management." Pharmacogenomics 16, no. 17 (November 10, 2015): 1931-1941. Full Text
  - Allen LaPointe, NM, Dai, D, Thomas, L, Piccini, JP, Peterson, ED, and Al-Khatib, SM. "Comparisons of hospitalization rates among younger atrial fibrillation patients receiving different antiarrhythmic drugs." Circulation. Cardiovascular Quality and Outcomes 8, no. 3 (May 2015): 292-300. Full Text
  - Haga, SB, Allen LaPointe, NM, and Moaddeb, J. "Challenges to integrating pharmacogenetic testing into medication therapy management." Journal of managed care & specialty pharmacy 21, no. 4 (April 2015): 346-352. (Review) Full Text
  - Allen LaPointe, NM, Dai, D, Thomas, L, Piccini, JP, Peterson, ED, and Al-Khatib, SM. "Antiarrhythmic drug use in patients <65 years with atrial fibrillation and without structural heart disease." The American Journal of Cardiology 115, no. 3 (February 2015): 316-322. Full Text
  - Allen LaPointe, NM, Dai, D, Thomas, L, Piccini, JP, Peterson, ED, and Al-Khatib, SM. "Antiarrhythmic drug use in patients <65 years with atrial fibrillation and without structural heart disease." American Journal of Cardiology 115, no. 3 (February 1, 2015): 316-322. Full Text
  - Kuntz, JL, Safford, MM, Singh, JA, Phansalkar, S, Slight, SP, Her, QL, Lapointe, NA, Mathews, R, O'Brien, E, Brinkman, WB, Hommel, K, Farmer, KC, Klinger, E, Maniam, N, Sobko, HJ, Bailey, SC, Cho, I, Rumptz, MH, Vandermeer, ML, and Hornbrook, MC. "Patient-centered interventions to improve medication management and adherence: a qualitative review of research findings." Patient education and counseling 97, no. 3 (December 2014): 310-326. (Review) Full Text
  - Haga, SB, Allen LaPointe, NM, Moaddeb, J, Mills, R, Patel, M, and Kraus, WE. "Pilot study: incorporation of pharmacogenetic testing in medication therapy management services." Pharmacogenomics 15, no. 14 (November 2014): 1729-1737. Full Text
  - Thomas, KL, Shah, BR, Elliot-Bynum, S, Thomas, KD, Damon, K, Allen LaPointe, NM, Calhoun, S, Thomas, L, Breathett, K, Mathews, R, Anderson, M, Califf, RM, and Peterson, ED. "Check it, change it: a community-based, multifaceted intervention to improve blood pressure control." Circulation. Cardiovascular Quality and Outcomes 7, no. 6 (November 2014): 828-834. Full Text
  - Haga, SB, LaPointe, NMA, Cho, A, Reed, SD, Mills, R, Moaddeb, J, and Ginsburg, GS. "Pilot study of pharmacist-assisted delivery of pharmacogenetic testing in a primary care setting." Pharmacogenomics 15, no. 13 (September 2014): 1677-1686. Full Text
  - Piccini, JP, Al-Khatib, SM, Wojdyla, DM, Shaw, LK, Horton, JR, Lokhnygina, Y, Anstrom, KJ, DeWald, T, Allen-LaPointe, N, Steinberg, BA, Thomas, K, Daubert, JP, and Peterson, ED. "Comparison of safety of sotalol versus amiodarone in patients with atrial fibrillation and coronary artery disease." The American Journal of Cardiology 114, no. 5 (September 2014): 716-722. Full Text
  - Al-Khatib, SM, Allen LaPointe, NM, Chatterjee, R, Crowley, MJ, Dupre, ME, Kong, DF, Lopes, RD, Povsic, TJ, Raju, SS, Shah, B, Kosinski, AS, McBroom, AJ, and Sanders, GD. "Rate- and rhythm-control therapies in patients with atrial fibrillation: a systematic review." Annals of Internal Medicine 160, no. 11 (June 2014): 760-773. (Review) Full Text
  - Allen LaPointe, NM, Lokhnygina, Y, Rimmler, J, Sanders, GD, Peterson, ED, and Al-Khatib, SM. "Use Of Rate And Rhythm Control Drugs In Patients Younger Than 65 Years With Atrial Fibrillation." Journal of Atrial Fibrillation 7, no. 1 (January 2014): 22-30.
  - Haga, SB, and LaPointe, NMA. "The potential impact of pharmacogenetic testing on medication adherence." Pharmacogenomics J 13, no. 6 (December 2013): 481-483. Full Text Link to Item
  - Haga, SB, and Lapointe, NMA. "The potential impact of pharmacogenetic testing on medication adherence." Pharmacogenomics Journal 13, no. 6 (December 1, 2013): 481-483. Full Text
  - Shah, BR, Thomas, KL, Elliot-Bynum, S, Thomas, K, Damon, K, Allen LaPointe, N, Calhoun, SA, Thomas, L, Mathews, R, Califf, RM, and Peterson, ED. "Check it, change it: a community-based intervention to improve blood pressure control." Circulation. Cardiovascular Quality and Outcomes 6, no. 6 (November 12, 2013): 741-748. Full Text
  - Allen LaPointe, NM, Lokhnygina, Y, Sanders, GD, Peterson, ED, and Al-Khatib, SM. "Adherence to guideline recommendations for antiarrhythmic drugs in atrial fibrillation." American Heart Journal 166, no. 5 (November 2013): 871-878. Full Text
  - Allen Lapointe, NM, Lokhnygina, Y, Sanders, GD, Peterson, ED, and Al-Khatib, SM. "Adherence to guideline recommendations for antiarrhythmic drugs in atrial fibrillation." American Heart Journal 166, no. 5 (November 1, 2013): 871-878. Full Text
  - Thomas, KL, Zimmer, LO, Dai, D, Al-Khatib, SM, Allen LaPointe, NM, and Peterson, ED. "Educational videos to reduce racial disparities in ICD therapy via innovative designs (VIVID): a randomized clinical trial." American Heart Journal 166, no. 1 (July 2013): 157-163. Full Text
  - Thomas, KL, Zimmer, LO, Dai, D, Al-Khatib, SM, Lapointe, NMA, and Peterson, ED. "Educational videos to reduce racial disparities in ICD therapy via innovative designs (VIVID): A randomized clinical trial." American Heart Journal 166, no. 1 (2013): 157-163.e2. Full Text
  - Willis, JM, Edwards, R, Anstrom, KJ, Johnson, FS, Del Fiol, G, Kawamoto, K, Lapointe, NMA, Eisenstein, EL, and Lobach, DF. "Decision support for evidence-based pharmacotherapy detects adherence problems but does not impact medication use." Stud Health Technol Inform 183 (2013): 116-125. Link to Item
  - Thomas, KL, Shah, BR, Elliott-Bynum, S, Thomas, KD, Damon, K, Lapointe, NA, Calhoun, S, Thomas, L, Breathett, K, Mathews, R, Anderson, M, Califf, RM, and Peterson, ED. "Check It Change It: A Community Based Hypertension Program." Circulation 126, no. 21 (November 20, 2012). Link to Item
  - American College of Clinical Pharmacy, , Hume, AL, Kirwin, J, Bieber, HL, Couchenour, RL, Hall, DL, Kennedy, AK, LaPointe, NMA, Burkhardt, CDO, Schilli, K, Seaton, T, Trujillo, J, and Wiggins, B. "Improving care transitions: current practice and future opportunities for pharmacists." Pharmacotherapy 32, no. 11 (November 2012): e326-e337. Full Text
  - Atwater, BD, Dai, D, Allen-Lapointe, NM, Al-Khatib, SM, Zimmer, LO, Sanders, GD, and Peterson, ED. "Is heart failure guideline adherence being underestimated? The impact of therapeutic contraindications." American Heart Journal 164, no. 5 (November 2012): 750-755.e1. Full Text
  - Calvert, SB, Kramer, JM, Anstrom, KJ, Kaltenbach, LA, Stafford, JA, and Allen LaPointe, NM. "Patient-focused intervention to improve long-term adherence to evidence-based medications: a randomized trial." American Heart Journal 163, no. 4 (April 2012): 657-65.e1. Full Text
  - Allen LaPointe, NM, Ou, F-S, Calvert, SB, Melloni, C, Stafford, JA, Harding, T, Peterson, ED, and Alexander, KP. "Association between patient beliefs and medication adherence following hospitalization for acute coronary syndrome." American Heart Journal 161, no. 5 (May 2011): 855-863. Full Text
  - LaPointe, NMA, Al-Khatib, SM, Piccini, JP, Atwater, BD, Honeycutt, E, Thomas, K, Shah, BR, Zimmer, LO, Sanders, G, and Peterson, ED. "Extent of and reasons for nonuse of implantable cardioverter defibrillator devices in clinical practice among eligible patients with left ventricular systolic dysfunction." Circulation. Cardiovascular Quality and Outcomes 4, no. 2 (March 2011): 146-151. Full Text
  - Del Fiol, G, Kawamoto, K, Lapointe, NMA, Eisenstein, EL, Anstrom, KJ, Wood, LL, and Lobach, DF. "Improving Medication Adherence in a Regional Healthcare Information Exchange using a Scalable, Claims-Driven, and Service-Oriented Approach. (Published online)" AMIA Annu Symp Proc 2010 (November 13, 2010): 137-141. Link to Item
  - Allen LaPointe, NM, Ou, F-S, Calvert, SB, Melloni, C, Stafford, JA, Harding, T, Alexander, KP, and Peterson, ED. "Changes in beliefs about medications during long-term care for ischemic heart disease." American Heart Journal 159, no. 4 (April 2010): 561-569. Full Text
  - LaPointe, NMA, Sun, J-L, and Kaplan, S. "In-hospital management of patients with atrial flutter." Am Heart J 159, no. 3 (March 2010): 370-376. Full Text Link to Item
  - Allen LaPointe, NM, Chen, AY, Roe, MT, Cohen, DJ, Diercks, DB, Hoekstra, JW, Fesmire, FM, Gibler, WB, Ohman, EM, and Peterson, ED. "Relation of patient age and mortality to reported contraindications to early beta-blocker use for non-ST-elevation acute coronary syndrome." The American Journal of Cardiology 104, no. 10 (November 2009): 1324-1329. Full Text
  - LaPointe, NMA, Stafford, JA, Pappas, PA, Al-Khatib, SM, and Anstrom, KJ. "Use of beta-blockers in patients with an implantable cardioverter defibrillator." The Annals of Pharmacotherapy 43, no. 7 (July 2009): 1189-1196. Full Text
  - Melloni, C, Alexander, KP, Ou, F-S, LaPointe, NMA, Roe, MT, Newby, LK, Baloch, K, Ho, PM, Rumsfeld, JS, and Peterson, ED. "Predictors of early discontinuation of evidence-based medicine after acute coronary syndrome." The American Journal of Cardiology 104, no. 2 (July 2009): 175-181. Full Text
  - Allen LaPointe, NM, Zhou, Y, Stafford, JA, Hernandez, AF, Kramer, JM, and Anstrom, KJ. "Association between mortality and persistent use of beta blockers and angiotensin-converting enzyme inhibitors in patients with left ventricular systolic dysfunction and coronary artery disease." Am J Cardiol 103, no. 11 (June 1, 2009): 1518-1524. Full Text Link to Item
  - Melloni, C, Alexander, KP, Chen, AY, Newby, LK, Roe, MT, Allen LaPointe, NM, Pollack, CV, Gibler, WB, Ohman, EM, Peterson, ED, and CRUSADE Investigators, . "Unfractionated heparin dosing and risk of major bleeding in non-ST-segment elevation acute coronary syndromes." American Heart Journal 156, no. 2 (August 2008): 209-215. Full Text
  - Alexander, KP, Chen, AY, Wang, TY, Rao, SV, Newby, LK, LaPointe, NMA, Ohman, EM, Roe, MT, Boden, WE, Harrington, RA, Peterson, ED, and CRUSADE Investigators, . "Transfusion practice and outcomes in non-ST-segment elevation acute coronary syndromes." American Heart Journal 155, no. 6 (June 2008): 1047-1053. Full Text
  - Allen Lapointe, NM, Sun, J-L, Kaplan, S, d'Almada, P, and Al-Khatib, SM. "Rhythm versus rate control in the contemporary management of atrial fibrillation in-hospital." Am J Cardiol 101, no. 8 (April 15, 2008): 1134-1141. Full Text Link to Item
  - Allen LaPointe, NM, Governale, L, Watkins, J, Mulgund, J, and Anstrom, KJ. "Outpatient use of anticoagulants, rate-controlling drugs, and antiarrhythmic drugs for atrial fibrillation." Am Heart J 154, no. 5 (November 2007): 893-898. Full Text Link to Item
  - Kawamoto, K, Allen LaPointe, NM, Silvey, GM, Anstrom, KJ, Eisenstein, EL, and Lobach, DF. "Development and evaluation of an improved methodology for assessing adherence to evidence-based drug therapy guidelines using claims data. (Published online)" AMIA Annu Symp Proc (October 11, 2007): 394-398. Link to Item
  - LaPointe, NMA, Chen, AY, Alexander, KP, Roe, MT, Pollack, CV, Lytle, BL, Ohman, ME, Gibler, BW, and Peterson, ED. "Enoxaparin dosing and associated risk of in-hospital bleeding and death in patients with non ST-segment elevation acute coronary syndromes." Archives of Internal Medicine 167, no. 14 (July 2007): 1539-1544. Full Text
  - Allen LaPointe, NM, Pappas, P, Deverka, P, and Anstrom, KJ. "Patient receipt and understanding of written information provided with isotretinoin and estrogen prescriptions." Journal of General Internal Medicine 22, no. 1 (January 2007): 98-101. Full Text
  - Swanson, J, and Swartz, M. "Authors' reply [4]." British Journal of Psychiatry 191, no. OCT. (2007): 358-359. Full Text
  - Kramer, JM, Hammill, B, Anstrom, KJ, Fetterolf, D, Snyder, R, Charde, JP, Hoffman, BS, Allen LaPointe, N, and Peterson, E. "National evaluation of adherence to beta-blocker therapy for 1 year after acute myocardial infarction in patients with commercial health insurance." American Heart Journal 152, no. 3 (September 2006): 454.e1-454.e8. Full Text
  - Newby, LK. "Response to Letter Regarding Article, "Long-Term Adherence to Evidence-Based Secondary Prevention Therapies in Coronary Artery Disease"." Circulation 114, no. 6 (August 8, 2006): e241-e241. Full Text
  - Allen LaPointe, NM, Curtis, LH, Chan, KA, Kramer, JM, Lafata, JE, Gurwitz, JH, Raebel, MA, and Platt, R. "Frequency of high-risk use of QT-prolonging medications." Pharmacoepidemiol Drug Saf 15, no. 6 (June 2006): 361-368. Full Text Link to Item
  - Allen LaPointe, NM, DeLong, ER, Chen, A, Hammill, BG, Muhlbaier, LH, Califf, RM, and Kramer, JM. "Multifaceted intervention to promote β-blocker use in heart failure." American Heart Journal 151, no. 5 (May 1, 2006): 999-1005. Full Text
  - LaPointe, NMA, DeLong, ER, Chen, A, Hammill, BG, Muhlbaier, LH, Califf, RM, and Kramer, JM. "Multifaceted intervention to promote beta-blocker use in heart failure." American Heart Journal 151, no. 5 (May 2006): 992-998. Full Text
  - Newby, LK, LaPointe, NMA, Chen, AY, Kramer, JM, Hammill, BG, DeLong, ER, Muhlbaier, LH, and Califf, RM. "Long-term adherence to evidence-based secondary prevention therapies in coronary artery disease." Circulation 113, no. 2 (January 9, 2006): 203-212. Full Text
  - LaPointe, NMA, and Kramer, JM. "Authors' reply." American Heart Journal 152, no. 4 (2006): e45-. Full Text
  - Alexander, KP, Chen, AY, Roe, MT, Newby, LK, Gibson, CM, Allen-LaPointe, NM, Pollack, C, Gibler, WB, Ohman, EM, Peterson, ED, and CRUSADE Investigators, . "Excess dosing of antiplatelet and antithrombin agents in the treatment of non-ST-segment elevation acute coronary syndromes." Jama 294, no. 24 (December 2005): 3108-3116. Full Text
  - Al-Khatib, SM, Allen LaPointe, NM, Kramer, JM, Chen, AY, Hammill, BG, Delong, L, and Califf, RM. "A survey of health care practitioners' knowledge of the QT interval." Journal of General Internal Medicine 20, no. 5 (May 2005): 392-396. Full Text
  - Cowper, PA, DeLong, ER, Whellan, DJ, Allen LaPointe, NM, and Califf, RM. "Economic effects of beta-blocker therapy in patients with heart failure." The American Journal of Medicine 116, no. 2 (January 2004): 104-111. Full Text
  - Newby, LK, Bhapkar, MV, White, HD, Moliterno, DJ, LaPointe, NMA, Kandzari, DE, Verheugt, FWA, Kramer, JM, Armstrong, PW, Califf, RM, and SYMPHONY and 2nd SYMPHONY investigators, . "Aspirin use post-acute coronary syndromes: intolerance, bleeding and discontinuation." Journal of Thrombosis and Thrombolysis 16, no. 3 (December 2003): 119-128. Full Text
  - Allen LaPointe, NM, Chen, A, Hammill, B, DeLong, E, Kramer, JM, and Califf, RM. "Evaluation of the dofetilide risk-management program." American Heart Journal 146, no. 5 (November 2003): 894-901. Full Text
  - LaPointe, NMA, Pamer, CA, and Kramer, JM. "New antiarrhythmic agents for atrial fibrillation and atrial flutter: United States drug market response as an indicator of acceptance." Pharmacotherapy 23, no. 10 (October 2003): 1316-1321. Link to Item
  - Krantz, MJ, Martell, BA, Arnsten, JH, and Gourevitch, MN. "Medications that prolong the QT interval." Jama 290, no. 8 (August 2003): 1025-null. (Letter) Full Text
  - LaPointe, NMA, and Jollis, JG. "Medication errors in hospitalized cardiovascular patients." Arch Intern Med 163, no. 12 (June 23, 2003): 1461-1466. Full Text Link to Item
  - Al-Khatib, SM, LaPointe, NMA, Kramer, JM, and Califf, RM. "What clinicians should know about the QT interval." Jama 289, no. 16 (April 2003): 2120-2127. (Review) Full Text
  - LaPointe, NMA, Al-Khatib, SM, Kramer, JM, and Califf, RM. "Knowledge deficits related to the QT interval could affect patient safety." Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc 8, no. 2 (April 2003): 157-160. Full Text
  - Curtis, LH, Østbye, T, Sendersky, V, Hutchison, S, Allen LaPointe, NM, Al-Khatib, SM, Usdin Yasuda, S, Dans, PE, Wright, A, Califf, RM, Woosley, RL, and Schulman, KA. "Prescription of QT-prolonging drugs in a cohort of about 5 million outpatients." The American Journal of Medicine 114, no. 2 (February 2003): 135-141. Full Text
  - Al-Khatib, SM, LaPointe, NMA, Curtis, LH, Kramer, JM, Swann, J, Honig, P, and Califf, RM. "Outpatient prescribing of antiarrhythmic drugs from 1995 to 2000." The American Journal of Cardiology 91, no. 1 (January 2003): 91-94. Full Text
  - LaPointe, NMA, Pamer, CA, and Kramer, JM. "New antiarrhythmic agents for atrial fibrillation and atrial flutter: United States drug market response as an indicator of acceptance." Pharmacotherapy 23, no. 10 II (2003): 1316-1321. Full Text
  - LaPointe, NMA, Kramer, JM, Weinfurt, KP, and Califf, RM. "Practitioner acceptance of the dofetilide risk-management program." Pharmacotherapy 22, no. 8 (August 2002): 1041-1046. Full Text
  - Allen LaPointe, NM, Kramer, JM, DeLong, ER, Ostbye, T, Hammill, BG, Muhlbaier, LH, McCants, CB, Chen, A, and Califf, RM. "Patient-reported frequency of taking aspirin in a population with coronary artery disease." The American Journal of Cardiology 89, no. 9 (May 2002): 1042-1046. Full Text
  - Califf, RM, DeLong, ER, Ostbye, T, Muhlbaier, LH, Chen, A, LaPointe, NA, Hammill, BG, McCants, CB, and Kramer, JM. "Underuse of aspirin in a referral population with documented coronary artery disease." The American Journal of Cardiology 89, no. 6 (March 2002): 653-661. Full Text
  - Allen LaPointe, NM, and Li, P. "Continuous intravenous quinidine infusion for the treatment of atrial fibrillation or flutter: a case series." Am Heart J 139, no. 1 Pt 1 (January 2000): 114-121. Link to Item
  - LaPointe, NMA, and Li, P. "Continuous intravenous quinidine infusion for the treatment of atrial fibrillation or flutter: A case series." American Heart Journal 139, no. 1 I (2000): 114-121.
  - Williamson, KM, Thrasher, KA, Fulton, KB, LaPointe, NM, Dunham, GD, Cooper, AA, Barrett, PS, and Patterson, JH. "Digoxin toxicity: an evaluation in current clinical practice." Arch Intern Med 158, no. 22 (December 7, 1998): 2444-2449. Link to Item
  - Allen, NM, and Page, RL. "Procainamide administration during pregnancy." Clin Pharm 12, no. 1 (January 1993): 58-60. Link to Item
  - Allen, NM. "Relationship between serum quinidine concentration and quinidine dosage." Pharmacotherapy 12, no. 3 (1992): 189-194. Link to Item
  - Allen, NM, Dunham, GD, Sailstad, JM, and Findlay, JW. "Clinical and pharmacokinetic profiles of digoxin immune Fab in four patients with renal impairment." DICP 25, no. 12 (December 1991): 1315-1320. Link to Item
  - Allen, NM. "Retreatment with digoxin immune Fab." Clin Pharm 10, no. 11 (November 1991): 823-824. (Letter) Link to Item
  - Allen, NM, and Dunham, GD. "Treatment of digitalis intoxication with emphasis on the clinical use of digoxin immune Fab." DICP 24, no. 10 (October 1990): 991-998. (Review) Link to Item
- Book Sections
  - Willis JM, , Edwards, R, Anstrom, KJ, Johnson, FS, Del Fiol, G, Kawamoto, K, Allen lapointe, NM, Eisenstein, EL, and Lobach, DF. "Decision Support for Evidence-Based Pharmacotherapy Detects Adherence Problems but Does Not Impact Medication Use." In Enabling Health and Healthcare Through ICT, edited by KL Courtney, O Shabestari, and A Kuo, 116-125. IOS Press, 2013.
  - Allen LaPointe, NM. "Pharmacoepidemiology And Therapeutic Risk Management." In Pharmacoepidemiology And Therapeutic Risk Management, edited by AG Hartzema. Harvey Whitney Books Company, February 28, 2008.
  - Allen LaPointe, NM. "Pharmacoepidemiology And Therapeutic Risk Management." In Pharmacoepidemiology And Therapeutic Risk Management, edited by AG Hartzema. Harvey Whitney Books Company, February 28, 2008.
- Conference Papers
  - Duan-Porter, W, Goldstein, KM, McDuffie, J, Hughes, JM, Clowse, M, Klap, R, Masilamani, V, LaPointe, NA, Nagi, A, Gierisch, JM, and Williams, JW. "MAPPING THE EVIDENCE: INTERVENTION SEX EFFECTS FOR DEPRESSION, DIABETES, AND CHRONIC PAIN." May 2016. Link to Item
  - Pokorney, S, Yen, DC, Campbell, K, LaPointe, NA, and Al-Khatib, S. "RECONSIDERING APPROPRIATE DOFETILIDE DOSING IN WOMEN." March 2015. Full Text
  - Kramer, JM, Chen, AY, Hammill, BG, DeLong, ER, LaPointe, NA, Muhlbaier, LH, McCants, CB, and Califf, RM. "Time trends and factors associated with outpatient beta-blocker use in patients with heart failure or left ventricular dysfunction." May 25, 2004. Link to Item
  - Kramer, JM, Fetterolf, D, Charde, JP, Snyder, R, Hammill, B, DeLong, E, Hoffman, BS, Arrington, RL, LaPointe, NA, and Peterson, ED. "National evaluation of adherence to beta-blocker therapy for one year after acute myocardial infarction in patients with commercial health insurance." May 25, 2004. Link to Item
  - Al-Khatib, SM, LaPointe, NMA, Kramer, JM, Chen, AY, Hammill, BG, DeLong, L, and Califf, RM. "A national survey of health care practitioners' knowledge of the QT interval." March 3, 2004. Full Text Link to Item
  - Kramer, JM, Fetterolf, D, Charde, JP, Snyder, R, Checkman, D, DeLong, E, LaPointe, NA, Hoffman, B, Arrington, RL, and Peterson, E. "838-4 National evaluation of long-term adherence to beta-blocker therapy after acute myocardial infarction in patients with commercial health insurance." March 2004. Full Text
  - Cowper, PA, Delong, ER, Whellan, DJ, Lapointe, NA, and Califf, RM. "Economic impact of beta-blocker therapy in patients with congestive heart failure." October 15, 2002. Link to Item
- Reports
  - Al-Khatib, SM, Allen LaPointe, N, Chatterjee, R, Crowley, MJ, Dupre, ME, Kong, DF, Lopes, RD, Povsic, TJ, Raju, SS, Kosinski, A, McBroom, AJ, Chobot, MM, Gray, R, and Sanders, GD. Treatment of Atrial Fibrillation. Comparative Effectiveness Review 119. Rockville, MD: AHRQ Publication, June 28, 2013.
  - DOLOR, RJ, Melloni, C, Chatterjee, R, Allen Lapointe, N, williams, JB, Coeytaux, RR, McBroom, AJ, Musty, MD, Wing, L, Samsa, GP, and Patel, MR. Treatment Strategies for Women With Coronary Artery Disease. August 1, 2012.

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.

Education, Training, & Certifications

Duke Appointment History

Selected Grants

Selected Publications

Academic Articles

Book Sections

Conference Papers

Reports